Developing and validating a prediction tool for cerebral amyloid angiopathy neuropathological severity

Documenti analoghi

• Exploring epidemiological risk factors for cerebral amyloid angiopathy: Considerations for monoclonal antibody therapy in people with Alzheimer's disease
  di: Liwei Ma, et al.
  Pubblicazione: (2025)
• Developing a machine learning stack model to forecast the progression of mild cognitive impairment to Alzheimer’s dementia, using the Australian Imaging, Biomarker & Lifestyle (AIBL) Study dataset
  di: Chenyin Chu, et al.
  Pubblicazione: (2024)
• Development and validation of a predictive model to forecast the cerebrovascular risk burden in older people using the NACC and ROSMAP dataset
  di: Chenyin Chu, et al.
  Pubblicazione: (2025)
• Leveraging Routine Blood Tests, Plasma pTau‐217, and Machine Learning for Enhanced Detection and Monitoring of Preclinical Alzheimer's Disease
  di: Liwei Ma, et al.
  Pubblicazione: (2025)
• Glial changes as result of cerebral amyloid angiopathy progression
  di: Katelynn E. Krick, et al.
  Pubblicazione: (2024)